Table 1. Associations between CXCL1 expression and clinicopathologic variables of HCC patients n (%).

Clinical characteristic		CXCL1		P-value
	All cases (n= 119)	High expression	Low expression
Gender(Female/Male)				0.712
Female	19	13 (16.9)	6 (14.3)
Male	100	64 (83.1)	36 (85.7)
Cirrhosis				0.156
No	18	9 (11.7)	9 (21.4)
Yes	101	68 (88.3)	33 (78.6)
AFP (≥ 400/< 400)				0.024
≥ 400 ng/mL	35	28 (36.4)	7 (16.7)
< 400 ng/mL	84	49 (63.6)	35 (83.3)
HBV-DNA (Positive/Negative)				0.982
Positive (≥ 5.0 × 102)	65	35 (45.5)	19 (45.2)
Negative (< 5.0 × 102)	54	42 (54.5)	23 (54.8)
Microvascular invasion (Yes/No)				0.321
Yes	32	23 (29.9)	9 (21.4)
No	87	54 (70.1)	33 (78.6)
TNM stage (I/II/III)				0.099
I	67	38 (49.4)	29 (69.0)
II	28	20 (26.0)	8 (19.0)
III	24	19 (24.7)	5 (11.9)
Differentiation (Poorly/Moderately - Well)				0.001
Poorly	33	25 (32.5)	2 (4.8)
Moderately - Well	86	52 (67.5)	40 (95.2)
Tumor size (≥ 5 cm/< 5 cm)				0.683
≥ 5 cm	65	36 (46.8)	18 (42.9)
< 5 cm	54	41 (53.2)	24 (57.1)